Sort
15,842 grants matching “pancreatic cancer”
Discovery of small molecule inhibitors of GalNAc-type O-linked glycosylation
$322,073Jennifer J Kohler · Ut Southwestern Medical Center · R01 · FY2018 · GM
Role of nutrient sensor O-GlcNAc transferase in regulating cancer
$322,051Mauricio J. Reginato · Drexel University · R01 · FY2012 · CA
Molecular Mediators of Pancreatic Cancer Invasion and Progression
$322,040Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
Dissecting Hedgehog, TGF beta and BMP Signaling During Pancreatic Tumorigenesis
$321,989Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · CA
Suppression of pancreatic tumorigenesis by the PTF1 transcription factor network
$321,988Lewis C Murtaugh · University Of Utah · R01 · FY2018 · CA
Protease Activated Receptors in Cancer Invasion
$321,925Tufts Medical Center · R01 · FY2005 · CA
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach
$321,843Stephen K. Van Den Eeden · Kaiser Foundation Research Institute · U01 · FY2019 · DK
Phase I/II clinical evaluation of ABTL0812, a novel PI3K/Akt/mTOR inhibitor, with a unique mechanism of action inpancreatic cancer (Protocol sent on 20th June 2019 as an amendment of the IND 137394)
$321,772Davendra Sohal · University Of Cincinnati · R01 · FY2024 · FD
BRAVE hydrogels for interrogating cell-matrix interactions in pancreatic desmoplasia
$321,759Chien-Chi Lin · Indiana University Indianapolis · R01 · FY2021 · CA
BRAVE hydrogels for interrogating cell-matrix interactions in pancreatic desmoplasia
$321,759Chien-Chi Lin · Indiana University Indianapolis · R01 · FY2020 · CA
BRAVE hydrogels for interrogating cell-matrix interactions in pancreatic desmoplasia
$321,759Chien-Chi Lin · Indiana University Indianapolis · R01 · FY2022 · CA
Enhancing immune therapy in pancreatic cancer by targeting IL-6
$321,742Gregory B. Lesinski · Emory University · R01 · FY2018 · CA
UBAP2, A New Molecule in Pancreatic Cancer Progression
$321,736Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · CA
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
$321,646Ann Marie Pendergast · Duke University · R01 · FY2012 · CA
Experimental Therapeutics
$321,634Israel David Goldman · Albert Einstein College Of Medicine, Inc · P30 · FY2016 · CA
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer
$321,631Richard Z Lin · State University New York Stony Brook · R01 · FY2009 · CA
Role of PKC iota in metaplasia and initiation of pancreatic cancer
$321,625Nicole R Murray · Mayo Clinic Jacksonville · R01 · FY2011 · CA
High dose radiation therapy to direct immune responses to pancreatic cancer
$321,625Michael James Gough · Providence Portland Medical Center · R01 · FY2015 · CA
Targeting a non-canonical RAS-driven pathway in pancreatic cancer
$321,625David A Cheresh · University Of California, San Diego · R01 · FY2016 · CA
Targeting a non-canonical RAS-driven pathway in pancreatic cancer
$321,625David A Cheresh · University Of California, San Diego · R01 · FY2015 · CA
High dose radiation therapy to direct immune responses to pancreatic cancer
$321,625Michael James Gough · Providence Portland Medical Center · R01 · FY2018 · CA
High dose radiation therapy to direct immune responses to pancreatic cancer
$321,625Michael James Gough · Providence Portland Medical Center · R01 · FY2017 · CA
Role of PKC iota in metaplasia and initiation of pancreatic cancer
$321,625Nicole R Murray · Mayo Clinic Jacksonville · R01 · FY2015 · CA
Targeting a non-canonical RAS-driven pathway in pancreatic cancer
$321,625David A Cheresh · University Of California, San Diego · R01 · FY2012 · CA
Role of PKC iota in metaplasia and initiation of pancreatic cancer
$321,625Nicole R Murray · Mayo Clinic Jacksonville · R01 · FY2012 · CA